GROINSS-V III - Radiochemotherapie bij een uitzaaiing in de schildwachtklier
- Conditions
- Vulvar cancerSentinel node procedureLymph node metastasisVulvacarcinoomSchildwachtklierprocedureLymfogene metastasen
- Registration Number
- NL-OMON22105
- Lead Sponsor
- niversity Medical Center Groningen
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 157
Inclusion Criteria
In order to be eligible to participate in this study, a subject must meet all of the following criteria:
- Histological confirmed primary SCC of the vulva
Exclusion Criteria
A potential subject who meets any of the following criteria will be excluded from participation in this study:
- Inoperable tumors and tumors > 4cm
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Groin recurrence rate in the first two years after primary treatment.
- Secondary Outcome Measures
Name Time Method - Treatment related morbidity (CTC AE v 4.0)<br /><br>- Disease-specific survival<br /><br>- Patient-reported quality of life <br>